Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
Eman Z. Elrazaz, Rabah A.T. Serya, Nasser S.M. Ismail and 2 more
Future Journal of Pharmaceutical Sciences · 2015
doi:10.1016/j.fjps.2015.09.001 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Thienopyrimidines are fused heterocyclic ring systems; structurally resemble purines, exerting pharmacological potential in different aspects. They are known to play a crucial role in various disease conditions. Thieno[2,3-d]pyrimidine derivatives have been explored for their inhibitory activities towards various protein kinase enzymes. The present review is a compilation on chemical synthesis and biological anticancer significance, via inhibition of specific protein kinase enzymes, including structure–activity relationships of thieno[2,3-d]pyrimidines derivatives reported to date.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.